News

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...